- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00337753
Cognitive Behavioral Therapy for Pathological Gambling
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Subjects will be assigned to counseling or be given a referral list of available Gamblers Anonymous meetings at the first visit based on answers to questions. Assignment to counseling or Gamblers Anonymous will be randomly selected (i.e. chance) with an equal chance of receiving either one. For those assigned to counseling, you will meet with the therapist for 60 minutes weekly. You will receive 5 sessions of counseling.
All subjects will be assessed with gambling questionnaires twice during the 5-week period and again at 3 and 6 months following the 5-week period.
For those assigned to Gamblers Anonymous, they will be offered 5 weeks of counseling at the end of the 6-month follow-up.
Type d'étude
Inscription (Réel)
Phase
- Phase 2
Contacts et emplacements
Lieux d'étude
-
-
Minnesota
-
Minneapolis, Minnesota, États-Unis, 55454
- University of Minnesota Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Outpatient men and women age 18 to 75
- Presence of current DSM-IV pathological gambling for at least 6 months duration
- PG is the most problematic psychiatric disorder (in the patient's and clinician's opinion) and the primary reason for seeking treatment
- Minimum score of >5 on the South Oaks Gambling Screen which reflects gambling severity consistent with pathological gambling
Exclusion Criteria:
- Current clinically significant suicidality, severe depression (a score of ≥ 19 on the Hamilton Rating Scale for Depression, 17-item version)(30) or any other disorder requiring immediate intervention
- Presence of any clinical features requiring a higher level of care than outpatient treatment
- Cognitive impairment that interferes with the capacity to engage in CBT or to provide informed consent
- DSM-IV substance abuse or dependence within the past 3 months (see Screening Visit)
- Current Axis I diagnosis of bipolar disorder or psychotic disorder
- Previous treatment of CBT for PG (duration of at least 6 sessions); because CBT is not widely used for PG, a minimum of 6 treatments will be rare.
- Current use of psychotropic medications or within 2 months prior to study entry.
- Current participation in Gambler's Anonymous (GA).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Cognitive Behavioral Therapy
Weekly Cognitive Behavior therapy
|
5-weeks of Cognitive Behavioral Therapy
Autres noms:
|
|
Autre: Wait-list
Subjects in wait-list for six-weeks
|
subjects assigned to wait-list condition for six-weeks
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
PG-YBOCS
Délai: At each visit prior to and after therapy has been completed
|
At each visit prior to and after therapy has been completed
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Time spent gambling
Délai: At each visit prior to and after therapy has been completed
|
At each visit prior to and after therapy has been completed
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 0503M68191
- K23MH069754-01A1 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .